Moje portfolio
Oblíbené tituly
select
NameBest
buy
Best
sell
Change
(%)
ČEZ0.00
KB0.00
PKN146.8146.84-1.24
Msft0.10
Nokia9.96
IBM-0.95
Mercedes-Benz Group AG48.01548.0151.22
PFE0.15
13/06/2026 02:04:00
Indices online
AD index online
select
AD index online
Patria Direct
Patria DirectThings our clients appreciate most: A large and experienced team of professional brokers, customer care support, stable and secure trading platform, unique news and information service. Try our demo account and see for yourself.

Free services: Patria Plus news services, analytical reports, account opening and keeping, submitting and cancelling orders, FX conversions. Moreover, for active traders we also offer free real-time data and Investor Plus services.
 

  • 11/06/2026
Antibiotice SA (ROATB.BX, Bucharest)
Close at 11.6.2026 Change (%) Change (RON) Turnover (RON)
2.03 1.00 0.02 28,124
R - Real-Time data can be activated by Patria Plus / Investor Plus clients HERE.

 
  • Latest update: 13/06/2026
Company description
General information
Company nameAntibiotice SA
TickerATB
Ordinary sharesOrdinary Shares
RICATB.BX
ISINROATBIACNOR9
Last annual results31/12/2025
Last interim results31/03/2026
Number of emploees as of 31/12/2025 1 356
Shares outstanding as of 31/03/2026 671 338 040
CurrencyRON
Contact information
StreetVALEA LUPULUI
CityIASI
Zip code707410
CountryRomania
Contact personCerasela Moraru
Function of contact personInvestor Relation Officer
Phone40 232 209 000
Fax40232209633
Contact phone400 372 065 583

Business Summary: Antibiotice SA is a Romania-based company primarily active in the pharmaceutical industry. The Company manufactures drugs in five pharmaceutical forms: powder for injectable solutions and suspensions, capsules, tablets, suppositories and preparations. The Company's products are designed to treat a range of diseases, including infectious, dermatology, cardiovascular, digestive and musculoskeletal system related. The Company operates eight certified production lines. Its portfolio includes products for human and veterinary use, pharmaceutical ingredients and biological fertilizers. Additionally, the Company is engaged in the research and development activities.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Antibiotice SA revenues decreased 15% to RON136.5M. Net income decreased 62% to RON12.6M. Revenues reflect Revenuesfrom the sale offinished product decrease of 13% to RON111.5M, Revenuesfrom the sale ofproducts made on decrease of 23% to RON24.6M, Incomefrom the provision of services decrease of 44% to RON424K.
Sector classification
TRBC2012Pharmaceuticals (NEC)
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICS2007Pharmaceutical Preparation Mfg
NAICS1997Pharmaceutical Preparation Manufacturing
SICPharmaceutical Preparations



  • Latest update: 13/06/2026
Company management
FunctionNameAgeOfficer sinceIn company since
President of the Management BoardLucian Timofticiuc-24/06/202124/06/2021
Executive Vice Chairman, Chief Executive OfficerIoan Nani5926/04/201201/01/1994
Economic/Financial DirectorPaula Coman5106/06/201106/06/2011
Technical and Production DirectorCornelia Moraru53
Engineering and Investments DirectorEugen Osadet64
Research and Development DirectorCristina Diaconescu51
Marketing and Domestic Sales DirectorOvidiu Bataga41
Marketing and International Market Sales DirectorDelia Racoveanu47
Commercial/Business and Logistics DirectorVasile Chebac64
Human Resources DirectorGica Rusu56